Oragenics, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Adaptimmune, TCR² Combine Forces, Incre

Mydecine, JHU Expand Pact Focused Initially On Smoking Cessation Mydecine Innovations Group Inc. and Johns Hopkins University said on 18 August that they will undertake a five-year collaboration t

Marquee investor Goldman Sachs has snapped up a “significant minority stake” in Aragen Life Sciences, the erstwhile India-based GVK Biosciences Pvt. Ltd. , backing the contract research organization’

Company Changes BENSON , Trey To: XBiotech Inc. , VP, Commercial Dev. & Mktg. (June) From: Edgemont Pharmaceuticals, VP, Mktg. Phone: 512-386-2900 BISHOP , John E. To: Genocea Biosciences I